Volume 37 Issue 3
May  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2021  >  37(3): 411-418
HUANG Li-hua, SHEN Hua, HAN Yi. Preparation and in vivo and in vitro Study of Piperine-Theanine Co-Amorphous Complex[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 411-418. doi: 10.14148/j.issn.1672-0482.2021.0411
Citation: HUANG Li-hua, SHEN Hua, HAN Yi. Preparation and in vivo and in vitro Study of Piperine-Theanine Co-Amorphous Complex[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 411-418. doi: 10.14148/j.issn.1672-0482.2021.0411
shu

Preparation and in vivo and in vitro Study of Piperine-Theanine Co-Amorphous Complex

doi: 10.14148/j.issn.1672-0482.2021.0411

  • Zhangjiagang Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, China

  • Received Date: 2020-06-14
    Available Online: 2021-12-21
  • Publish Date: 2021-05-10
    Abstract
  • OBJECTIVE  To prepare piperine-theanine co-amorphous complex (PIP-THE CAC) and improve dissolution and bioavailability of PIP.METHODS  The PIP-THE CAC was prepared by quench cooling, characterized by DSC, XRPD, FTIR, SEM and evaluated by in vitro dissolution under sink and non-sink conditions. The physical stability of PIP-THE CAC was also investigated. Besides, the bioavailability study of PIP-THE CAC was conducted by pharmacokinetic tests in rats.RESULTS  DSC and XRPD indicated that PIP-THE CAC was successfully prepared. FTIR confirmed that there was intermolecular hydrogen bond interaction between PIP and THE in the prepared CAC, resulting in excellent physical stability. SEM showed that the CAC was irregular, lumpy and granular, and the characteristics of PIP and THE were disappeared. Besides, compared with pure PIP and PIP-THE physical mixture, PIP-THE CAC possessed a higher dissolution rate and a higher dissolution degree, and maintained supersaturated degree for long time in vitro dissolution experiments. Pharmacokinetic results showed that Cmax, tmax, AUC0-24 h and AUC0-∞ of PIP-THE CAC group increased significantly (P < 0.01) compared with raw PIP, and the Cmax and bioavailability of PIP increased by 2.03 and 1.93 times, respectively (P < 0.01).CONCLUSION  PIP-THE CAC prepared by THE co-amorphization with PIP can effectively improve the solubility/dissolution and oral bioavailability of PIP.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    MA ZG, YUAN YP, ZHANG X, et al. Piperine attenuates pathological cardiac fibrosis via PPAR-γ/AKT Pathways[J]. EbioMedicine, 2017, 18: 179-187. doi: 10.1016/j.ebiom.2017.03.021
    [2]
    白音夫, 杨宏昕. 荜茇挥发油对动物实验性胃溃疡的保护作用[J]. 中草药, 2000, 31(1): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO200001021.htm
    [3]
    LEE SA, HONG SS, HAN XH, et al. Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity[J]. Chem Pharm Bull, 2005, 53(7): 832-835. doi: 10.1248/cpb.53.832
    [4]
    SUNILA ES, KUTTAN G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine[J]. J Ethnopharmacol, 2004, 90(2/3): 339-346. http://www.onacademic.com/detail/journal_1000035405045810_f399.html
    [5]
    ONONIWU IM, IBENEME CE, EBONG OO. Effects of piperine on gastric acid secretion in albino rats[J]. Afr J Med Med Sci, 2002, 31(4): 293-295. http://europepmc.org/abstract/MED/15027765
    [6]
    KHAJURIA A, THUSU N, ZUTSHI U, et al. Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa[J]. Mol Cell Biochem, 1998, 189(1/2): 113-118. doi: 10.1023/A:1006877614411
    [7]
    DOGRA RKS, KHANNA S, SHANKER R. Immunotoxicological effects of piperine in mice[J]. Toxicology, 2004, 196(3): 229-236. doi: 10.1016/j.tox.2003.10.006
    [8]
    吴珍菊, 夏学进, 黄雪松. 胡椒碱平衡溶解度和表观油水分配系数的测定[J]. 暨南大学学报(自然科学与医学版), 2012, 33(5): 473-476. doi: 10.3969/j.issn.1000-9965.2012.05.008
    [9]
    余丹妮, 伍薇, 祁玮玮, 等. 女贞子三萜-胡椒碱共无定型复合物的表征和体外溶出度评价[J]. 中草药, 2018, 49(3): 561-568. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201803009.htm
    [10]
    HSU CM, YU SC, TSAI FJ, et al. Characterization of in vitro and in vivo bioactivity of a ferulic acid-2-Hydroxypropyl-β-cyclodextrin inclusion complex[J]. Colloids Surf B Biointerfaces, 2019, 180: 68-74. doi: 10.1016/j.colsurfb.2019.04.020
    [11]
    AHMED S, CORVIS Y, GAHOUAL R, et al. Conception of nanosized hybrid liposome/poloxamer particles to thicken the interior core of liposomes and delay hydrophilic drug delivery[J]. Int J Pharm, 2019, 567: 118488. doi: 10.1016/j.ijpharm.2019.118488
    [12]
    VASCONCELOS T, MARQUES S, DAS NEVES J, et al. Amorphous solid dispersions: Rational selection of a manufacturing process[J]. Adv Drug Deliv Rev, 2016, 100: 85-101. doi: 10.1016/j.addr.2016.01.012
    [13]
    ABDULKARIM M, SHARMA PK, GUMBLETON M. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies[J]. Adv Drug Deliv Rev, 2019, 142: 62-74. doi: 10.1016/j.addr.2019.04.001
    [14]
    HOU GZ, WANG ZY, MA HG, et al. High-temperature stable plasmonic and cavity resonances in metal nanoparticle-decorated silicon nanopillars for strong broadband absorption in photothermal applications[J]. Nanoscale, 2019, 11(31): 14777-14784. doi: 10.1039/C9NR05019A
    [15]
    TRUBITSYN G, NGUYEN VN, DI TOMMASO C, et al. Impact of covalently Nile Red and covalently Rhodamine labeled fluorescent polymer micelles for the improved imaging of the respective drug delivery system[J]. Eur J Pharm Biopharm, 2019, 142: 480-487. doi: 10.1016/j.ejpb.2019.07.020
    [16]
    SHI XJ, SONG SJ, DING ZJ, et al. Improving the solubility, dissolution, and bioavailability of ibrutinib by preparing it in a coamorphous state with saccharin[J]. J Pharm Sci, 2019, 108(9): 3020-3028. doi: 10.1016/j.xphs.2019.04.031
    [17]
    FUNG MH, DEVAULT M, KUWATA KT, et al. Drug-excipient interactions: Effect on molecular mobility and physical stability of ketoconazole-organic acid coamorphous systems[J]. Mol Pharm, 2018, 15(3): 1052-1061. doi: 10.1021/acs.molpharmaceut.7b00932
    [18]
    CHAVAN RB, THIPPARABOINA R, KUMAR D, et al. Co amorphous systems: A product development perspective[J]. Int J Pharm, 2016, 515(1/2): 403-415. http://www.researchgate.net/profile/Rahul_Chavan13/publication/309292884_Co_Amorphous_Systems_A_Product_Development_Perspective/links/580afcca08aeef1bfee3fb42.pdf
    [19]
    OJARINTA R, HEIKKINEN AT, SIEVANEN E, et al. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin[J]. Eur J Pharm Biopharm, 2017, 112: 85-95. doi: 10.1016/j.ejpb.2016.11.023
    [20]
    LENZ E, JENSEN KT, BLAABJERG LI, et al. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine[J]. Eur J Pharm Biopharm, 2015, 96: 44-52. doi: 10.1016/j.ejpb.2015.07.011
    [21]
    LENZ E, LOBMANN K, RADES T, et al. Hot melt extrusion and spray drying of co-amorphous indomethacin-arginine with polymers[J]. J Pharm Sci, 2017, 106(1): 302-312. doi: 10.1016/j.xphs.2016.09.027
    [22]
    PETRY I, LOBMANN K, GROHGANZ H, et al. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions[J]. Int J Pharm, 2018, 544(1): 172-180. doi: 10.1016/j.ijpharm.2018.04.026
    [23]
    HENG WL, SU ML, CHENG H, et al. Incorporation of complexation into a coamorphous system dramatically enhances dissolution and eliminates gelation of amorphous lurasidone hydrochloride[J]. Mol Pharm, 2020, 17(1): 84-97. doi: 10.1021/acs.molpharmaceut.9b00772
    [24]
    WU W, LӦBMANN K, SCHNITZKEWITZ J, et al. Dipeptides as co-formers in co-amorphous systems[J]. Eur J Pharm Biopharm, 2019, 134: 68-76. doi: 10.1016/j.ejpb.2018.11.016
    [25]
    HUANG R, HAN J, WANG R, et al. Surfactant-free solid dispersion of BCS class Ⅳ drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro-permeability increase[J]. Eur J Pharm Sci, 2019, 130: 147-155. doi: 10.1016/j.ejps.2019.01.031
    [26]
    WANG RN, HAN JW, JIANG A, et al. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine[J]. Int J Pharm, 2019, 561: 9-18. doi: 10.1016/j.ijpharm.2019.02.027
    [27]
    黄容, 陆昕怡, 韩加伟, 等. 姜黄素-胡椒碱固体分散体的制备与生物利用度研究[J]. 中草药, 2018, 49(19): 4528-4534. doi: 10.7501/j.issn.0253-2670.2018.19.010
    [28]
    LOBMANN K, LAITINEN R, GROHGANZ H, et al. Coamorphous drug systems: Enhanced physical stability and dissolution rate of indomethacin and naproxen[J]. Mol Pharmaceutics, 2011, 8(5): 1919-1928. doi: 10.1021/mp2002973
    [29]
    BEVERNAGE J, BROUWERS J, BREWSTER ME, et al. Evaluation of gastrointestinal drug supersaturation and precipitation: Strategies and issues[J]. Int J Pharm, 2013, 453(1): 25-35. doi: 10.1016/j.ijpharm.2012.11.026
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(8)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (236) PDF downloads(110) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return